Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02724878
Title Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

renal cell carcinoma

Therapies

Atezolizumab + Bevacizumab + Capecitabine

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California, San Diego Moores Cancer Center La Jolla California 92037 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field